- Home
- FBIO vs VNRX Comparison
FBIO vs VNRX Comparison
Compare FBIO & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- VNRX
- Stock Information
- Founded
- FBIO 2006
- VNRX N/A
- Country
- FBIO United States
- VNRX United States
- Employees
- FBIO N/A
- VNRX N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- FBIO Health Care
- VNRX Health Care
- Exchange
- FBIO Nasdaq
- VNRX Nasdaq
- Market Cap
- FBIO 49.1M
- VNRX 52.4M
- IPO Year
- FBIO N/A
- VNRX N/A
- Fundamental
- Price
- FBIO $1.89
- VNRX $0.51
- Analyst Decision
- FBIO Strong Buy
- VNRX Strong Buy
- Analyst Count
- FBIO 3
- VNRX 4
- Target Price
- FBIO $21.00
- VNRX $4.17
- AVG Volume (30 Days)
- FBIO 178.7K
- VNRX 263.7K
- Earning Date
- FBIO 05-15-2025
- VNRX 05-15-2025
- Dividend Yield
- FBIO N/A
- VNRX N/A
- EPS Growth
- FBIO N/A
- VNRX N/A
- EPS
- FBIO N/A
- VNRX N/A
- Revenue
- FBIO $57,784,000.00
- VNRX $1,308,361.00
- Revenue This Year
- FBIO $63.20
- VNRX $563.72
- Revenue Next Year
- FBIO $66.70
- VNRX $160.43
- P/E Ratio
- FBIO N/A
- VNRX N/A
- Revenue Growth
- FBIO N/A
- VNRX 64.16
- 52 Week Low
- FBIO $1.33
- VNRX $0.40
- 52 Week High
- FBIO $2.89
- VNRX $0.90
- Technical
- Relative Strength Index (RSI)
- FBIO 60.90
- VNRX 54.00
- Support Level
- FBIO $1.66
- VNRX $0.40
- Resistance Level
- FBIO $1.96
- VNRX $0.52
- Average True Range (ATR)
- FBIO 0.11
- VNRX 0.04
- MACD
- FBIO 0.01
- VNRX 0.00
- Stochastic Oscillator
- FBIO 80.56
- VNRX 78.64
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.